{ }
001122334455554433221100
001122334455554433221100

moncyte health secures funding to enhance personalized treatments for high cholesterol

MONCYTE Health has secured €1 million in seed funding to enhance its personalized treatment technology for high cholesterol, a major cardiovascular risk factor. The investment, led by Finnish venture capital firms, aims to advance a unique diagnostic approach that quantifies cellular lipid uptake, enabling tailored therapies for patients. This innovative technology promises to improve cholesterol management and reduce cardiovascular disease risk by providing insights into the cellular mechanisms involved.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.